Increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries & wound healing applications; the rising number of hip & knee replacement procedures; and the increasing demand for implantable devices are responsible for the significant growth of the market during the review period.

COVID-19 Impact on the global Medical Ceramics Market
The global spread of COVID-19 has led to the complete suspension of elective surgeries, especially in the most-affected countries. Some regions witnessed a 70% reduction in the number of patients seeking aesthetic treatments from January 2020 onwards. Moreover, several dental events have been postponed due to the COVID-19 pandemic.

For instance, KRAKDENT 2020, the largest dental show in Poland and an event that attracts over 15,000 visitors worldwide has been rescheduled. The CEO of Straumann Group announced that the COVID-19 outbreak was expected to reduce sales in the Asia Pacific in FY 2020 by at least USD 31 million. Additionally, DENTSPLY Sirona recently predicted that its sales in the Chinese, South Korean, Taiwanese, and Japanese markets would fall by a cumulative USD 60–70 million in FY 2020.

Medical Ceramics Market DynamicsDriver: Increasing demand for implantable devices
Medical implants are artificial devices that are used to replace damaged or missing biological parts. Implants help deliver medication, monitor body functions, and provide support to organs and tissues in different applications (such as dental, orthopedic, and cardiovascular). The medical implants market is driven by the growing healthcare needs of the senior population, advancements in medical technologies, and the rising incidence of chronic diseases, such as osteoarthritis, cardiovascular diseases, neuropathic diseases, and congenital disorders, among others.

In 2015, there were 901 million elderly individuals (aged 60 years and above) globally, and this figure is projected to grow by 56% to reach 1.4 billion by 2030 (Source: United Nations). Moreover, in the US, the population of individuals aged over 65 years is expected to double between 2005 and 2030 (Source: National Institute on Aging). Also, in Japan, 40% of the population is expected to be over 65 years by 2060 (WHO).

The significant growth in the geriatric population is expected to result in an increased demand for joint reconstruction, cardiovascular surgeries, and dental replacement procedures and an increase in the prevalence of hearing loss. These factors are, in turn, expected to support the growth of the hearing, orthopedic, and dental implants market.

For More Information Download, Request to Get PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129

The medical ceramics market in the APAC is estimated to grow rapidly during the forecast period, considering the development of the region’s healthcare sector. The major consumers of medical ceramics in the APAC are China, South Korea, and Japan. The aging population, increasing disposable income, technological advancements, and growing awareness about treatments available provide huge growth opportunities for HAp manufacturers in the region.

The major players operating in the medical ceramics market are CoorsTek, Inc. (US), CeramTec GmbH (Germany), KYOCERA Corporation (Japan), Morgan Advanced Materials (UK), Tosoh (Japan), Johnson & Johnson (US), Institut Straumann (Switzerland), 3M (US), Royal DSM (DSM) (Netherlands), Rauschert GmbH (Germany), Zimmer Biomet (US), NGK Spark Plug (Japan), H.C. Stark GmbH (Germany), Berkeley Advanced Biomaterials (US).

Recent Developments
In 2020, Institut Straumann AG (Switzerland) entered into a strategic partnership with XJet Ltd. (Israel) to develop Ceramic AM-based dental implants. Straumann is utilizing XJet’s NanoParticle Jetting technology to develop dental implants.
In 2019, KYOCERA Medical Technologies, Inc. (a subsidiary of KYOCERA Corporation) introduced the company’s novel products & technologies at the American Academy of Orthopedic Surgeons (AAOS) 2019 held in the US. The company has introduced Tesera Trabecular Technology, BIOCERAM AZUL Ceramic Heads, E-MAX Acetabular Liners, and Aquala Acetabular Liners.
In 2018, CoorsTek established a new R&D center in Uden, The Netherlands. This new European R&D center is dedicated to developing technical ceramics capabilities to support European customers. The opening of a new R&D facility in the Netherlands supports its strategy to expand capabilities in the European market.